Squarepoint’s PetMed Express PETS Stock Holding History

Squarepoint’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,000	Closed	-$151K	–	4462
2023 Q4	$151K	Buy	+20,000	New	+$164K	﹤0.01%	3676

Other funds holding PETS

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Squarepoint's PETS Position: Q1 2025 in Review

Squarepoint sold out of PetMed Express (PETS) in Q1 2025, closing a stake of 17,686 shares — an estimated $85.2K sold.

Squarepoint first reported a position in PETS in Q2 2017 and held it in 19 quarters. The position peaked at $9.07M in Q2 2018. 72 funds tracked by Wall St. Rank hold PETS as of Q1 2025.

Squarepoint reported no remaining PetMed Express position as of Q1 2025 after selling out during the quarter.
Squarepoint sold 17,686 PetMed Express shares in Q1 2025, an estimated $85.2K.
Squarepoint first reported a position in PetMed Express in Q2 2017 and held it in 19 quarters.
Squarepoint's PetMed Express position peaked at $9.07M in Q2 2018.
72 funds tracked by Wall St. Rank held PetMed Express as of Q1 2025.

Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.